PL371620A1 - Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases - Google Patents

Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases

Info

Publication number
PL371620A1
PL371620A1 PL03371620A PL37162003A PL371620A1 PL 371620 A1 PL371620 A1 PL 371620A1 PL 03371620 A PL03371620 A PL 03371620A PL 37162003 A PL37162003 A PL 37162003A PL 371620 A1 PL371620 A1 PL 371620A1
Authority
PL
Poland
Prior art keywords
aspirin
antithrombotic agent
novel association
treating
atherothrombotic diseases
Prior art date
Application number
PL03371620A
Other languages
English (en)
Polish (pl)
Inventor
Tony Verbeuren
Gilbert Lavielle
Bernard Cimetiere
Marie-Odile Vallez
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL371620A1 publication Critical patent/PL371620A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL03371620A 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases PL371620A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204222A FR2838057B1 (fr) 2002-04-05 2002-04-05 Nouvelle association d'un antithrombotique et d'aspirine

Publications (1)

Publication Number Publication Date
PL371620A1 true PL371620A1 (en) 2005-06-27

Family

ID=28052120

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371620A PL371620A1 (en) 2002-04-05 2003-04-04 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases

Country Status (26)

Country Link
US (1) US7618955B2 (enExample)
EP (1) EP1496884B1 (enExample)
JP (1) JP4065853B2 (enExample)
KR (1) KR100645143B1 (enExample)
CN (1) CN1297265C (enExample)
AR (1) AR039253A1 (enExample)
AT (1) ATE329591T1 (enExample)
AU (1) AU2003246774B2 (enExample)
BR (1) BR0309019A (enExample)
CA (1) CA2480697A1 (enExample)
CY (1) CY1105106T1 (enExample)
DE (1) DE60306133T2 (enExample)
DK (1) DK1496884T3 (enExample)
EA (1) EA006978B1 (enExample)
ES (1) ES2264533T3 (enExample)
FR (1) FR2838057B1 (enExample)
GE (1) GEP20074101B (enExample)
MA (1) MA27114A1 (enExample)
MX (1) MXPA04009760A (enExample)
NO (1) NO20044700L (enExample)
NZ (1) NZ535430A (enExample)
PL (1) PL371620A1 (enExample)
PT (1) PT1496884E (enExample)
UA (1) UA79457C2 (enExample)
WO (1) WO2003084525A1 (enExample)
ZA (1) ZA200407593B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMP200800012B (it) * 2005-07-22 2008-02-27 Procter & Gamble Composizioni per ridurre l'incidenza di aritmia indotta da farmaco
CN103071154A (zh) 2007-04-13 2013-05-01 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
JP2009001537A (ja) * 2007-06-25 2009-01-08 Lab Servier 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
US7618955B2 (en) 2009-11-17
UA79457C2 (en) 2007-06-25
EP1496884A1 (fr) 2005-01-19
NZ535430A (en) 2006-09-29
CN1297265C (zh) 2007-01-31
FR2838057A1 (fr) 2003-10-10
BR0309019A (pt) 2005-02-01
FR2838057B1 (fr) 2005-07-08
MA27114A1 (fr) 2004-12-20
DK1496884T3 (da) 2006-10-02
EA006978B1 (ru) 2006-06-30
ATE329591T1 (de) 2006-07-15
CY1105106T1 (el) 2009-11-04
ES2264533T3 (es) 2007-01-01
EP1496884B1 (fr) 2006-06-14
EA200401293A1 (ru) 2005-02-24
AU2003246774A1 (en) 2003-10-20
MXPA04009760A (es) 2004-12-13
AR039253A1 (es) 2005-02-16
GEP20074101B (en) 2007-05-10
NO20044700L (no) 2004-10-29
HK1076034A1 (en) 2006-01-06
WO2003084525A1 (fr) 2003-10-16
ZA200407593B (en) 2006-07-26
AU2003246774B2 (en) 2007-02-15
PT1496884E (pt) 2006-09-29
JP2005528376A (ja) 2005-09-22
DE60306133T2 (de) 2007-01-04
US20050143354A1 (en) 2005-06-30
KR100645143B1 (ko) 2006-11-10
KR20040098053A (ko) 2004-11-18
DE60306133D1 (de) 2006-07-27
CN1646111A (zh) 2005-07-27
CA2480697A1 (fr) 2003-10-16
JP4065853B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
PL375052A1 (en) Pharmaceutical pig and method of use
SI1487541T1 (sl) Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja
EP1487446A4 (en) BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES
AU2003278832A8 (en) Optical biosensors and methods of use thereof
EP1567099A4 (en) IMPROVED STENT AND METHODS OF MANUFACTURE
EP1677705A4 (en) COATING EXTENSION DEVICE HAVING A FUNCTIONALITY DETERMINED BY ITS GEOMETRY AND METHOD OF MANUFACTURING THE SAME
AU2003223579A8 (en) Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003216586A8 (en) Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
IL162678A0 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
PT1487828E (pt) Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
GB0615918D0 (en) Composition and its therapeutic use
AU2003206945A8 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
GB0207410D0 (en) Compounds and their therapeutic use
PL371620A1 (en) Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
PL371251A1 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AU2003286068A1 (en) Process for the treatment of pig manure and the use thereof
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
SI1496884T1 (sl) Kombinacija antitrombotika in aspirina in njena uporaba za zdravljenje aterotromboticnih bolezni
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003208238A1 (en) Use of ppar alpha agonists for the treatment of vascular and renal diseases
IL164951A0 (en) The treatment of pain with lfendropil
AU2003279800A8 (en) Sulfatases and methods of use thereof
TWI339582B (en) Use of alkylphosphocholines in the preventive application of protozoal diseases

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)